🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Maryland › Baltimore

Etid klinik pou Maladi kadyovaskilè nan Baltimore, MD

13 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Baltimore
  • Clinical Trial Site, Baltimore
  • Clinical Trial Site, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Zenith® Fenestrated+ Clinical Study

Ap rekrite
  • University of Maryland, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT04875429

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Ap rekrite
  • The Johns Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • University of Maryland Medical Center, Baltimore
  • The Johns Hopkins Hospital, Baltimore
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Ap rekriteFaz 3
  • University of Maryland, Baltimore
  • Sinai Ct for Throm Res and Drug Dev, Baltimore
  • Johns Hopkins Univ School of Med, Baltimore
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Ap rekriteFaz 4Volontè an sante akeyi
  • Johns Hopkins University, Baltimore
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Ap rekriteEtid obsèvasyon
  • University of Maryland/Greenebaum Cancer Center, Baltimore
Laj 7 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Baltimore
  • Research Site, Baltimore
  • Research Site, Baltimore
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Ap rekriteFaz 3
  • Ascension Saint Agnes Heart Care, Baltimore
  • Johns Hopkins Hospital, Baltimore
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Ap rekrite
  • MedStar, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Ap rekrite
  • Johns Hopkins, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152

Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation Participation

Ap rekrite
  • Johns Hopkins Hospital, Baltimore
  • Johns Hopkins Bayview Medical Center, Baltimore
  • Johns Hopkins Hospital, Baltimore
Laj 21 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT06908590

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.